Mark Klausner

Mark Klausner has an extensive background in healthcare investment banking and equity capital markets. Currently, he serves as the Managing Partner at Westwicke Partners, LLC, where he provides customized investor relations strategies and independent capital markets advice to small and mid-cap healthcare companies. In addition to his current role, Mark also holds a position on the Board of Directors at Oxford Immunotec. With previous experience at reputable firms such as Wachovia Securities, Signal Hill Capital, Deutsche Bank, BT Alex. Brown, Alex. Brown & Sons, and Merrill Lynch, Mark brings a wealth of knowledge and expertise to the healthcare industry. He holds an MBA from the University of Virginia Darden School of Business and a BA in Economics/Computer Science from Colgate University.